{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:53:27Z","timestamp":1777517607703,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1124\/mol.104.005769","type":"journal-article","created":{"date-parts":[[2005,2,10]],"date-time":"2005-02-10T01:42:33Z","timestamp":1107999753000},"page":"1808-1817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Expression of the Retinoic Acid-Metabolizing Enzyme CYP26A1 Limits Programmed Cell Death"],"prefix":"10.1016","volume":"67","author":[{"given":"Makoto","family":"Osanai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Petkovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.104.005769_bib1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1101\/gad.855001","article-title":"The retinoic acid-metabolizing enzyme, CYP26A1, is essential for normal hindbrain patterning, vertebral identity and development of posterior structures","volume":"15","author":"Abu-Abed","year":"2001","journal-title":"Genes Dev"},{"key":"10.1124\/mol.104.005769_bib2","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1194\/jlr.M100343-JLR200","article-title":"HPLC-MS\/MS analysis of the products generated from all-trans-retinoic acid using recombinant human CYP26A","volume":"43","author":"Chithalen","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1124\/mol.104.005769_bib3","first-page":"339","article-title":"Nuclear retinoic-acid-binding proteins and receptors in retinoic-acid-responsive cell lines","volume":"57","author":"Daly","year":"1989","journal-title":"Exp Cell Biol"},{"key":"10.1124\/mol.104.005769_bib4","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1096\/fasebj.10.9.8801177","article-title":"Altered retinoic acid receptor","volume":"10","author":"de Th\u00e9","year":"1996","journal-title":"FASEB J"},{"key":"10.1124\/mol.104.005769_bib5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/340140a0","article-title":"Retinoic acid causes an anteroposterior transformation in the developing central nervous system","volume":"340","author":"Durston","year":"1989","journal-title":"Nature (Lond)"},{"key":"10.1124\/mol.104.005769_bib6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/35077213","article-title":"Proliferation, cell cycle and apoptosis in cancer","volume":"411","author":"Evan","year":"2001","journal-title":"Nature (Lond)"},{"key":"10.1124\/mol.104.005769_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00001622-199601000-00002","article-title":"Biology and treatment of acute promyelocytic leukemia","volume":"8","author":"Fenaux","year":"1996","journal-title":"Curr Opin Oncol"},{"key":"10.1124\/mol.104.005769_bib8","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1056\/NEJM199710093371509","article-title":"Differentiation therapy for acute promyelocytic anemia","volume":"337","author":"Fenaux","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1124\/mol.104.005769_bib9","doi-asserted-by":"crossref","first-page":"E255","DOI":"10.1038\/ncb1101-e255","article-title":"Organelle-specific initiation of cell death pathways","volume":"3","author":"Ferri","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1124\/mol.104.005769_bib10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0092-8674(94)90518-5","article-title":"Apoptosis in cancer therapy: crossing the threshold","volume":"78","author":"Fisher","year":"1994","journal-title":"Cell"},{"key":"10.1124\/mol.104.005769_bib11","first-page":"1460","article-title":"High-level expression of the retinoic acid receptor beta in normal cells of the uterine cervix is regulated by the retinoic acid receptor alpha and is abnormally down-regulated in cervical carcinoma cells","volume":"57","author":"Geisen","year":"1997","journal-title":"Cancer Res"},{"key":"10.1124\/mol.104.005769_bib12","doi-asserted-by":"crossref","first-page":"E159","DOI":"10.1038\/ncb0602-e159","article-title":"Life and death in paradise","volume":"4","author":"Gozani","year":"2002","journal-title":"Nat Cell Biol"},{"key":"10.1124\/mol.104.005769_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1535-6108(02)00024-7","article-title":"A matter of life and death","volume":"1","author":"Green","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1124\/mol.104.005769_bib14","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1101\/gad.13.15.1899","article-title":"BCL-2 family members and the mitochondria in apoptosis","volume":"13","author":"Gross","year":"1999","journal-title":"Genes Dev"},{"key":"10.1124\/mol.104.005769_bib15","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/carcin\/21.7.1271","article-title":"Retinoids in chemoprevention and differentiation therapy","volume":"21","author":"Hansen","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1124\/mol.104.005769_bib16","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1126\/science.278.5340.1073","article-title":"Recent advances in chemoprevention of cancer","volume":"278","author":"Hong","year":"1997","journal-title":"Science (Wash DC)"},{"key":"10.1124\/mol.104.005769_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/excr.1999.4397","article-title":"Induction of p21 (CIP1\/Waf1) and activation of p34 (cdc2) involved in retinoic acid-induced apoptosis in human hepatoma Hep3B cells","volume":"248","author":"Hsu","year":"1999","journal-title":"Exp Cell Res"},{"key":"10.1124\/mol.104.005769_bib18","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V72.2.567.567","article-title":"Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia","volume":"72","author":"Huang","year":"1988","journal-title":"Blood"},{"key":"10.1124\/mol.104.005769_bib19","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0092-8674(95)90202-3","article-title":"Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life?","volume":"83","author":"Kastner","year":"1995","journal-title":"Cell"},{"key":"10.1124\/mol.104.005769_bib20","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1054\/bjoc.2001.1952","article-title":"Metabolism and growth inhibition of four retinoids in head and neck squamous normal and malignant cells","volume":"85","author":"Klaassen","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1124\/mol.104.005769_bib21","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1096\/fasebj.10.9.8801164","article-title":"Retinoids in cancer chemoprevention","volume":"10","author":"Lotan","year":"1996","journal-title":"FASEB J"},{"key":"10.1124\/mol.104.005769_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0065-2571(00)00024-8","article-title":"Regulation of retinoic acid metabolism","volume":"41","author":"Luu","year":"2001","journal-title":"Adv Enzyme Regul"},{"key":"10.1124\/mol.104.005769_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0925-4773(01)00463-4","article-title":"Cloning of a novel retinoic-acid metabolizing cytochrome P450, Cyp26B1 and comparative expression analysis with Cyp26A1 during early murine development","volume":"107","author":"MacLean","year":"2001","journal-title":"Mech Dev"},{"issue":"3 Suppl","key":"10.1124\/mol.104.005769_bib24","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/1097-0142(19930201)71:3+<1068::AID-CNCR2820711427>3.0.CO;2-5","article-title":"Ketoconazole and liarozole in the treatment of advanced prostatic cancer","volume":"71","author":"Mahler","year":"1993","journal-title":"Cancer"},{"key":"10.1124\/mol.104.005769_bib25","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0092-8674(95)90200-7","article-title":"The RXR heterodimers and orphan receptors","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"key":"10.1124\/mol.104.005769_bib26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1146\/annurev.bi.64.070195.001221","article-title":"The roles of retinoids in vertebrate development","volume":"64","author":"Means","year":"1995","journal-title":"Annu Rev Biochem"},{"key":"10.1124\/mol.104.005769_bib27","first-page":"2138","article-title":"Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia","volume":"52","author":"Muindi","year":"1992","journal-title":"Cancer Res"},{"key":"10.1124\/mol.104.005769_bib28","first-page":"2896","article-title":"Phenobarbital causes apoptosis in conditionally immortalized mouse hepatocytes depending on deregulated c-myc expression: characterization of an unexpected effect","volume":"57","author":"Osanai","year":"1997","journal-title":"Cancer Res"},{"key":"10.1124\/mol.104.005769_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ajh.10099","article-title":"All-trans-retinoic acid-induced expression and regulation of retinoic acid 4-hydroxylase (CYP26) in human promyelocytic leukemia","volume":"70","author":"Ozpolat","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1124\/mol.104.005769_bib30","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/emboj\/17.6.1675","article-title":"Two CD95 (APO-1\/Fas) signaling pathways","volume":"17","author":"Scaffidi","year":"1998","journal-title":"EMBO (Eur Mol Biol Organ) J"},{"key":"10.1124\/mol.104.005769_bib31","first-page":"5479","article-title":"Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid response in SK-BR-3 and T47D human breast cancer cells","volume":"60","author":"Schneider","year":"2000","journal-title":"Cancer Res"},{"key":"10.1124\/mol.104.005769_bib32","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1567-133X(03)00066-8","article-title":"Cyp26C1 encodes a novel retinoic acid-metabolizing enzyme expressed in the hindbrain, inner ear, first brachial arch and tooth buds during murine development","volume":"3","author":"Tahayato","year":"2003","journal-title":"Gene Expr Patterns"},{"key":"10.1124\/mol.104.005769_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1074\/jbc.M308337200","article-title":"A novel cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid","volume":"279","author":"Taimi","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.104.005769_bib34","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/bjc.1998.207","article-title":"The antiproliferative activity of all-trans-retinoic acid catabolites and isomers is differentially modulated by liarozole-fumarate in MCF-7 human breast cancer cells","volume":"77","author":"Van Heusden","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1124\/mol.104.005769_bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/mc.10066","article-title":"Ketoconazole potentiates the antitumor effects of nocodazole: in vivo therapy for human tumor xenografts in nude mice","volume":"34","author":"Wang","year":"2002","journal-title":"Mol Carcinog"},{"key":"10.1124\/mol.104.005769_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/gad.10.1.1","article-title":"Life, death and the pursuit of apoptosis","volume":"10","author":"White","year":"1996","journal-title":"Genes Dev"},{"key":"10.1124\/mol.104.005769_bib37","doi-asserted-by":"crossref","first-page":"18538","DOI":"10.1074\/jbc.272.30.18538","article-title":"cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450","volume":"272","author":"White","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.104.005769_bib38","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1084\/jem.42.6.753","article-title":"Tissue changes following deprivation of fat-soluble A vitamin","volume":"42","author":"Wolbach","year":"1925","journal-title":"J Exp Med"},{"key":"10.1124\/mol.104.005769_bib39","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.275.5303.1129","article-title":"1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked","volume":"275","author":"Yang","year":"1997","journal-title":"Science (Wash DC)"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24067609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24067609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.104.005769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T09:05:22Z","timestamp":1740042322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24067609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0026895X24067609"],"URL":"https:\/\/doi.org\/10.1124\/mol.104.005769","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of the Retinoic Acid-Metabolizing Enzyme CYP26A1 Limits Programmed Cell Death","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.104.005769","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}